HLA Class II antigens are associated with resistance or susceptibility to hepatosplenic disease in a Chinese population infected with Schistosoma japonicum

International Journal for Parasitology

Volumn 28, Issue 4, 1998, Pages 537-542

  Waine, G J ^a   Ross, A G P ^a   Williams, G M ^a   Sleigh, A C ^a   McManus, D P ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Fibrosis; Hepatosplenic disease; HLA Class II antigens; Schistosoma japonicum; Schistosomiasis; Susceptibility resistance

Indexed keywords

HLA ANTIGEN CLASS 2;

ANTIGEN DETECTION; ARTICLE; CHINESE; CHROMOSOME 5Q; ENDEMIC DISEASE; FIBROSIS; GENE LOCATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HEPATOSPLENOMEGALY; IMMUNOGENICITY; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS;

ALLELES; ANIMALS; CHINA; DISEASE SUSCEPTIBILITY; GENES, MHC CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNITY, NATURAL; LIVER DISEASES, PARASITIC; MIDDLE AGED; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SPLENIC DISEASES;

JAPONICA; PROTOZOA; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA;

EID: 0032055345     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(98)00020-4     Document Type: Article

References (20)

1. [1] Wilkins AS. Genetics of the susceptibility to infectious diseases - First Louis Pasteur Conference on Infectious Diseases. BioEssays 1996;19:85-86.
2. [2] World Health Organisation. WHO fact sheet on schistosomiasis. WHO, Geneva. May 1996.
3. [3] Abel L, Demenais F, Prata A, et al. Evidence for the segregation of a major human gene in human susceptibility/ resistance to infection by Schistosoma mansoni. Am J Hum Genet 1991;48:959-970.
4. [4] Marquet S, Abel L, Hillaire D, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chomosome 5q31-q33. Nat Genet 1996;14:181-184.
5. [5] Secor WE, Corral H, dos Reis MG, et al. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. J Infect Dis 1996;174:1131-1135.
6. [6] Hill A, Allsopp C, Kwiatkowski D, et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991;352:595-600.
7. [7] Waine G, McManus DP. Schistosome vaccine development - the current picture. BioEssays 1997;19:435-443.
8. [8] Katz N, Chaves A, Pellergrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972;14:397-400.
9. [9] World Health Organisation. Meeting on ultrasonography in schistosomaisis. Proposal for a practical guide to the standardized use of ultrasound in the assessment of pathological changes. Geneva: World Health Organisation, 1991; mimeographed document No: TDR.SCH/ULTRASON/ 91.3.
10. [10] Bugawan TL, Erlich HA. Rapid typing of HLA-DQB1 DNA polymorphism using non-radioactive oligonucleotide probes and amplified DNA. Immunogenetics 1991;33:163-170.
11. [11] Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991, Proceedings of the 11th International Histocompatibility Workshop and Conference, vol 1. Oxford: Oxford University Press, 1992;397-419.
12. [12] Kirkwood BR. Essentials of medical statistics. Oxford: Blackwell Science, 1988;87-105.
13. [13] Moloney NA, Bickle QD, Webbe G. The induction of specific immunity against Schistosoma japonicum by exposure of mice to ultraviolet attenuated cercariae. Parasitology 1985;90:313-323.
14. [14] Bickle QD, Andrews BJ, Doenhoff MJ, Ford MJ, Taylor MG. Resistance against Schistosoma mansoni induced by highly irradiated infections: studies on species specificity of immunization and attempts to transfer resistance. Parasitology 1985;90:301-312.
15. [15] Moloney NA, Garcia EG, Webb G. The strain specificity of vaccination with ultra violet attenuated cercariae of the Chinese strain of Schistosoma japonicum. Trans R Soc Trop Med Hyg 1985;79:245-247.
16. [16] Kresina T, Guan X, Posner M, Ramirez B, Olds GR. Comparison of immune repertoires of Chinese and Philippine patients infected with Schistosoma japonicum. Infect Immun 1991;59:4698-4700.
17. [17] Kresina T, Cheever LW, Chireau M, et al. Human EBV-transformed lymphocytes of patients with Schistosoma japonicum infection secrete idiotypically related immunoregulatory antibodies. Clin Immunol Immunopathol 1992;65:325-329.
18. [18] Cheever AW, Williams ME, Wynn TA, et al. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 1994;153:753-759.
19. [19] Wynn TA, Cheever AW, Jankovic D, et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995;372:594-596.
20. [20] King CL, Xianli J, Malhotra I, et al. Mice with a targeted deletion of of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with schistosomiasis mansoni. J Immunol 1997;18:294-300.